SCHEMBL31228213

SCHEMBL31228213

Nc1ncnc2c1c(F)cn2[C@@H]1O[C@](F)(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 5/20 0.46
▸ P2RY2 P41231 5/20 0.46
▸ P2RY11 Q96G91 1/20 0.46
▸ P2RX1 P51575 4/20 0.44
▸ P2RX3 P56373 4/20 0.44
▸ P2RX2 Q9UBL9 2/20 0.44
▸ P2RX4 Q99571 3/20 0.41
▸ RNASEL Q05823 2/20 0.41
▸ ADK P55263 1/20 0.41
▸ SRC P12931 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ POLRMT O00411 1/20 0.40
▸ MACROD2 A1Z1Q3 1/20 0.39
▸ SIRT6 Q8N6T7 1/20 0.39
▸ MACROD1 Q9BQ69 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31228108 0.90 P2RY1 (0.45) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228115 0.85 ADORA3 (0.42) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL15828228 0.84 P2RX1 (0.63) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL15828310 0.84 P2RX1 (0.63) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228119 0.83 P2RY1 (0.46) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228238 0.81 P2RY1 (0.42) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL21078481 0.81 P2RY1 (0.42) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL19412751 0.80 P2RY1 (0.45) P2RY1P2RY2P2RY11P2RX1P2RX3
SCHEMBL31228253 0.80 ADK (0.51) ADKALDH1A1PRMT5WDR77
SCHEMBL20058714 0.78 P2RX1 (0.58) P2RY1P2RY2P2RX1P2RX3P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP claimed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO claimed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 — — EP disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 — — WO disclosed
Send feedback